What sector does GENOVIS AB SE-40 (5GV) operate in?
GENOVIS AB SE-40 belongs to the Healthcare sector and operates in the Biotechnology industry.
What is GENOVIS AB SE-40 (5GV) current stock price?
As of the latest data, GENOVIS AB SE-40 stock price is €1.99, with a previous close of €2.01. GENOVIS AB SE-40 lost -€0.01 in the last trading session, representing a -0.65% loss.
What is GENOVIS AB SE-40 (5GV) current market capitalization?
GENOVIS AB SE-40 market cap is approximately 130.41 million.
What is GENOVIS AB SE-40 (5GV) Earnings Per Share (EPS)?
The trailing EPS is €0.04.
What is GENOVIS AB SE-40 (5GV) Price-to-Earnings (P/E) ratio?
GENOVIS AB SE-40 current P/E ratio is 49.8.
Does GENOVIS AB SE-40 (5GV) pay dividends?
No. GENOVIS AB SE-40 does not pay a dividend.
When is GENOVIS AB SE-40 (5GV) next earnings report?
GENOVIS AB SE-40 is expected to release its next earnings report on September 30, 2025.
What is GENOVIS AB SE-40 (5GV) beta (volatility) score?
GENOVIS AB SE-40 has a beta of 1.874, suggesting it is more volatile than the market.